These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38562422)

  • 1. Editorial: Personalized precision medicine in autism spectrum related disorders, volume II.
    Gabis LV; Nissenkorn A; Barbaro J
    Front Neurol; 2024; 15():1392642. PubMed ID: 38562422
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Personalized Precision Medicine in Autism Spectrum-Related Disorders.
    Gabis LV; Gross R; Barbaro J
    Front Neurol; 2021; 12():730852. PubMed ID: 34650510
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcortical Brain Development in Autism and Fragile X Syndrome: Evidence for Dynamic, Age- and Disorder-Specific Trajectories in Infancy.
    Shen MD; Swanson MR; Wolff JJ; Elison JT; Girault JB; Kim SH; Smith RG; Graves MM; Weisenfeld LAH; Flake L; MacIntyre L; Gross JL; Burrows CA; Fonov VS; Collins DL; Evans AC; Gerig G; McKinstry RC; Pandey J; St John T; Zwaigenbaum L; Estes AM; Dager SR; Schultz RT; Styner MA; Botteron KN; Hazlett HC; Piven J;
    Am J Psychiatry; 2022 Aug; 179(8):562-572. PubMed ID: 35331012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Major Transcriptomics and Epitranscriptomics Contributions toward Personalized and Precision Medicine.
    Mubarak G; Zahir FR
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m).
    Beversdorf DQ; Anagnostou E; Hardan A; Wang P; Erickson CA; Frazier TW; Veenstra-VanderWeele J
    Front Psychiatry; 2022; 13():1079006. PubMed ID: 36741580
    [No Abstract]   [Full Text] [Related]  

  • 6. [FROM GENETICS OF FRAGILE X SYNDROME TO DEVELOPMENT OF TARGETED AND PERSONALIZED DRUG THERAPY].
    Gabis LV; Shefer S; Gruber N; Raviv R; Cohen Y; Berkenstadt M; Ries-Levavi L; Pinhas-Hamiel O; Elizur S
    Harefuah; 2018 Aug; 157(8):529-533. PubMed ID: 30175572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From de novo mutations to personalized therapeutic interventions in autism.
    Brandler WM; Sebat J
    Annu Rev Med; 2015; 66():487-507. PubMed ID: 25587659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biobehavioral composite of social aspects of anxiety in young adults with fragile X syndrome contrasted to autism spectrum disorder.
    Roberts JE; Ezell JE; Fairchild AJ; Klusek J; Thurman AJ; McDuffie A; Abbeduto L
    Am J Med Genet B Neuropsychiatr Genet; 2018 Oct; 177(7):665-675. PubMed ID: 30307687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of autism spectrum disorder symptoms on gesture use in fragile X syndrome and Down syndrome.
    Lorang E; Sterling A;
    Autism Dev Lang Impair; 2017; 2():. PubMed ID: 30345371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressive language abilities of boys with idiopathic autism spectrum disorder and boys with fragile X syndrome + autism spectrum disorder: Cross-context comparisons.
    Hilvert E; Sterling A; Haebig E; Friedman L
    Autism Dev Lang Impair; 2020; 5():2396941520912118. PubMed ID: 36381548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: Autism Symptoms in Infants with Fragile X Syndrome.
    Roberts JE; Tonnsen BL; McCary LM; Caravella KE; Shinkareva SV
    J Autism Dev Disord; 2016 Dec; 46(12):3830-3837. PubMed ID: 27628938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early social communication in infants with fragile X syndrome and infant siblings of children with autism spectrum disorder.
    Hahn LJ; Brady NC; McCary L; Rague L; Roberts JE
    Res Dev Disabil; 2017 Dec; 71():169-180. PubMed ID: 29040924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Autism: Genomic Stratification of Disorders Making Up the Broad Spectrum May Demystify Its "Epidemic Rates".
    Torres EB
    J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of Autism-associated genes in the brain of Fragile X mouse model.
    Zhang A; Shen CH; Ma SY; Ke Y; El Idrissi A
    Biochem Biophys Res Commun; 2009 Feb; 379(4):920-3. PubMed ID: 19138667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of precision medicine in autism.
    Kostic A; Buxbaum JD
    Neuron; 2021 Jul; 109(14):2212-2215. PubMed ID: 34293291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineating the profile of autism spectrum disorder characteristics in Cornelia de Lange and Fragile X syndromes.
    Moss J; Oliver C; Nelson L; Richards C; Hall S
    Am J Intellect Dev Disabil; 2013 Jan; 118(1):55-73. PubMed ID: 23301903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome.
    Boland MJ; Nazor KL; Tran HT; Szücs A; Lynch CL; Paredes R; Tassone F; Sanna PP; Hagerman RJ; Loring JF
    Brain; 2017 Mar; 140(3):582-598. PubMed ID: 28137726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive and self-injurious behaviors: associations with caudate volume in autism and fragile X syndrome.
    Wolff JJ; Hazlett HC; Lightbody AA; Reiss AL; Piven J
    J Neurodev Disord; 2013 May; 5(1):12. PubMed ID: 23639144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autism spectrum disorder in the fragile X premutation state: possible mechanisms and implications.
    Aishworiya R; Protic D; Hagerman R
    J Neurol; 2022 Sep; 269(9):4676-4683. PubMed ID: 35723724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of on-site clinical genetics consultations on diagnostic rate in children and young adults with autism spectrum disorder.
    Munnich A; Demily C; Frugère L; Duwime C; Malan V; Barcia G; Vidal C; Throo E; Besmond C; Hubert L; Roland-Manuel G; Malen JP; Ferreri M; Hanein S; Thalabard JC; Boddaert N; Assouline M
    Mol Autism; 2019; 10():33. PubMed ID: 31406558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.